Titlebook: Advances in Substance and Behavioral Addiction; The Role of Executiv Michela Balconi,Salvatore Campanella Book 2021 The Editor(s) (if appli

gonioscopy

懶惰人民

EFs in Pathological Gambling Disorderuals. An important element to consider concerns the behavioural deficits of patients with GD and the tools used to investigate them: in particular, this chapter analyses the role of the IGT in the assessment of EFs and, specifically, in reward sensitivity. The behavioural aspects of GD, indeed, are

LUDE

Neuroenhancement of the Executive Functions in Addictionments in stimulus–outcome representations, for example, increased future-based delay-discounting and decision-making, and rewiring of the dorsolateral and ventral PFC. The use and efficacy data of these four cognitive training programmes in behavioural addictions are still missing. The combination o

Harridan

Graves’-disease

Focus-Words

Interoception and Addiction: Etiological Mechanisms and a Root for Intervention model aimed at the interactions between implicit processes, interoceptive signalling and supervisory function; specific mindfulness-based interventions that can modulate both the interoceptive function and the insular activation patterns (i.e., mindful awareness in body-oriented therapy); and, fina

maroon

A Study of Interface for ROODA Environment,of addiction that takes into account the EFs impairment, the reward-system neural correlates (including anomalous lateralized response in cortical activity), and, in the meantime, the possibility to implement new future treatment approach, including neuromodulation or neurostimulation techniques, ai

obsolete

N. Joglar,J.L. Risco,A. Díaz,J.M. ColmenarF and psychopathology, beginning from a functional outline of EF and from their neurofunctional correlates, and then moving to the complex relationship between EF, neurocognitive deficits, and clinical manifestation of psychopathology. In particular, while pointing out the transdiagnostic role of ne

boisterous

Sandra Lopes,Pedro Henriques,Paulo Diastion on neurocognitive deficits in addiction and on commonly-used cognitive screening tools, presents a novel neurocognitive screening tool—named Battery for Executive Functions in Addiction (BFE-A)—devised to provide an answer to the clinical need for neuropsychological assessment tools in drug tre

ABYSS